NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 283 filers reported holding NEOGENOMICS INC in Q1 2022. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $360,796 | -23.5% | 29,333 | 0.0% | 0.03% | -38.2% |
| Q2 2023 | $471,381 | -7.7% | 29,333 | 0.0% | 0.06% | -9.8% |
| Q1 2023 | $510,688 | +88.4% | 29,333 | 0.0% | 0.06% | +69.4% |
| Q4 2022 | $271,037 | +7.1% | 29,333 | 0.0% | 0.04% | -5.3% |
| Q3 2022 | $253,000 | +5.9% | 29,333 | 0.0% | 0.04% | +5.6% |
| Q2 2022 | $239,000 | -34.5% | 29,333 | -2.3% | 0.04% | -25.0% |
| Q1 2022 | $365,000 | -63.5% | 30,030 | +2.4% | 0.05% | -63.9% |
| Q4 2021 | $1,001,000 | -29.3% | 29,333 | 0.0% | 0.13% | -34.8% |
| Q3 2021 | $1,415,000 | +6.9% | 29,333 | 0.0% | 0.20% | +26.7% |
| Q2 2021 | $1,324,000 | -6.4% | 29,333 | 0.0% | 0.16% | -30.9% |
| Q1 2021 | $1,414,000 | -13.4% | 29,333 | -3.3% | 0.23% | -32.1% |
| Q4 2020 | $1,633,000 | – | 30,333 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
| Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
| First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
| PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
| EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
| Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
| FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
| OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
| Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |